Log in to search using one of your social media accounts:

 

FDA Approves MRI Software for Fatty Liver Disease Screening FDA Approves MRI Software for Fatty Liver Disease Screening
The diagnosis of nonalcoholic fatty liver disease, which can rapidly progress to cirrhosis or liver cancer, could become easier with new multiparametric MRI software.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2017 Category: Consumer Health News Tags: Radiology News Source Type: news

Non-invasive Tools for Diagnosis of Liver Fibrosis in NAFLD Non-invasive Tools for Diagnosis of Liver Fibrosis in NAFLD
Can serial use of non-invasive methods such as evaluation of imaging studies, clinical scores, and biochemical markers accurately diagnose advanced liver fibrosis in patients with NAFLD?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 4, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Clearance For Perspectum Diagnostics' LiverMultiScan(TM) Means More Patients Can Benefit From Access To State-Of-The-Art Non-Invasive Diagnostic Aid For Liver Disorders
More patients can benefit from non-invasive assessment of the liver through expanded compatibility with MRI systems LiverMultiScan™ comprehensive analysis allows the clinician to visualize heterogeneous liver tissue and assist in clinical decision-makin... Diagnostics, Radiology, FDA Perspectum Diagnostics, LiverMultiScan, NAFLD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 27, 2017 Category: Pharmaceuticals Source Type: news

New Treatments in Non-alcoholic Fatty Liver Disease New Treatments in Non-alcoholic Fatty Liver Disease
An improved understanding of the mechanisms behind NAFLD has led to new approaches to pharmacotherapy. This review presents an overview of current and investigational therapeutics.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 27, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Trends and Outcomes of NAFLD-HCC After Liver Resection Trends and Outcomes of NAFLD-HCC After Liver Resection
This review examined temporal trends for prevalence, clinical characteristics and outcomes of NAFLD-related HCC. Do these differ from HCC that developed in patients with other chronic liver diseases?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 22, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Ground-breaking € 34 million project to develop better test for liver disease
(European Association for the Study of the Liver) A pioneering European research project aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) and identify those most at risk for developing severe inflammation and liver scarring. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 21, 2017 Category: International Medicine & Public Health Source Type: news

NAFLD Linked to Increased Cancer Incidence Rate
NAFLD strongly tied to development of hepatocellular carcinoma, CRC in males, breast cancer in females (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 20, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Radiology, Journal, Source Type: news

Ground-breaking € 34 million project to develop better test for liver disease
(Newcastle University) A pioneering European research project aims to lead to new diagnostic tests to assess patients with non-alcoholic fatty liver disease (NAFLD) and identify those most at risk for developing severe inflammation and liver scarring. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2017 Category: International Medicine & Public Health Source Type: news

NAFLD Linked to Higher Incidence Rates of Cancer (CME/CE)
(MedPage Today) -- Significantly associated with HCC, colon cancer in men, and breast cancer in women (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 15, 2017 Category: Gastroenterology Source Type: news

Nonalcoholic fatty liver disease increases risk of liver, colorectal, and breast cancers
(Elsevier) Nonalcoholic fatty liver disease (NAFLD) is one of the more common chronic liver diseases worldwide. It is associated with metabolic syndrome (i.e. insulin resistance and diabetes) and predisposes to cardiovascular disease. In a new study published in the Journal of Hepatology, researchers identified links not only between NAFLD and hepatocellular carcinoma (HCC), which have been well established, but also to cancers outside the liver, including colorectal and breast cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2017 Category: Cancer & Oncology Source Type: news

A'Wake- up Call' for Burnout; More From WCOG at ACG 2017 A'Wake- up Call' for Burnout; More From WCOG at ACG 2017
Dr David Johnson provides his takeaways from this meeting. Part 1 reveals a'wake-up call'for gastroenterologist burnout and updates in bariatric surgery, Barrett esophagus, G-POEM, NAFLD, and more.Medscape Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 7, 2017 Category: Consumer Health News Tags: Gastroenterology Commentary Source Type: news

Living with NASH: An Unexpected Diagnosis
As our waistlines thicken and our activity levels decrease, another chronic illness threatens to disturb our comfortable lifestyles. And, because it ’s relatively unknown, diagnosis comes as a shock to patients, who usually associate liver disease with heavy consumption of alcohol.Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD), where fat accumulates in the liver. It is most commonly associated with obesity, insulin resistance, metabolic syndrome and/or genetic polymorphisms, and is aggravated by inflammation and fibrosis.  First identified in the 1980s, its ...
Source: EyeForPharma - November 3, 2017 Category: Pharmaceuticals Authors: Mariel Metcalfe Source Type: news

Probiotics and Omega-3s for Fatty Liver Cut Steatosis Risk Probiotics and Omega-3s for Fatty Liver Cut Steatosis Risk
Preventing and treating nonalcoholic fatty liver disease is a growing challenge, but Ukrainian investigators have successfully translated their promising animal findings to the clinical setting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 2, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Women With NAFLD at Higher Risk of Heart Disease
(MedPage Today) -- Risk increases for angina, heart attack, heart failure (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 23, 2017 Category: Cardiology Source Type: news

Even "healthy people," if they eat sugar, are at risk for heart disease, new study finds
(Natural News) New research reveals that even healthy people who consume a high-sugar diet are prone to heart disease. To reach this conclusion, researchers from the University of Surrey in the United Kingdom examined two groups of men, 11 of whom had a fatty liver or also known as non-alcoholic fatty liver disease (NAFLD), while... (Source: NaturalNews.com)
Source: NaturalNews.com - October 23, 2017 Category: Consumer Health News Source Type: news

NAFLD in Hispanic Youth With Dysglycemia NAFLD in Hispanic Youth With Dysglycemia
A new study examines the impacts of NAFLD on endothelial function and the risk for subclinical atherosclerosis among obese Hispanic adolescents.Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

NAFLD Increases Risk for Cardiovascular Events in Women NAFLD Increases Risk for Cardiovascular Events in Women
In the general population, women tend to be at lower risk for cardiovascular events than men, but the presence of nonalcoholic fatty liver disease appears to change that, a new study finds.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Weight Loss in Italy?
One of the women I work with wanted to know about the new diet drug called Belviq. The FDA is always approving a new “miracle” weight-loss pill, only to recall it a few years later. To date, at least 34 diet drugs have been taken off the market. Diet pills cause all kinds of problems — heart attack, stroke and psychiatric disorders. And Belviq isn’t any different. Some of its side effects include suicidal thoughts, a racing heartbeat, hallucinations and more… The European Union banned Belviq. The reason? It causes cancer in animals.  And here’s the real irony… Clinical tri...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

Prostate problem? Take 2 nuts
By age 60, you have a 50/50 chance of having a clinically enlarged prostate. And it only gets worse every year. When your prostate isn’t functioning properly, it’s hard to enjoy life. Traditional doctors give you two choices. Go under the knife or you take Big Pharma’s drugs. Either way, you have a good chance of ending up with your manhood on the line… If you have surgery, there’s a big risk you’ll be saying goodbye to your sex life for good. The rate of impotence is a shocking 50 to 60% after prostate surgery.1 Big Pharma’s meds to shrink your prostate are no better. These sy...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

Fatty Liver Disease Fastest-growing Reason for Transplants in Young U.S. Adults Fatty Liver Disease Fastest-growing Reason for Transplants in Young U.S. Adults
Nonalcoholic fatty liver disease and its more aggressive form, nonalcoholic steatohepatitis, have become the fastest-growing reasons for liver transplants in young Americans, according to a recent study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 18, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news

Fatty liver disease fastest-growing reason for transplants in young U.S. adults
(Reuters Health) - Nonalcoholic fatty liver disease and its more aggressive form, nonalcoholic steatohepatitis, have become the fastest-growing reasons for liver transplants in young Americans, according to a recent study. (Source: Reuters: Health)
Source: Reuters: Health - October 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Medical News Today: High-sugar diets raise heart disease risk in healthy people
A study finds that a high-sugar diet changes a healthy person's fat metabolism so that it resembles that of someone with non-alcoholic fatty liver disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 6, 2017 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Worse than liquor for your liver
Most people think liver disease only happens to alcoholics. But the truth is that being overweight or obese actually puts you at a much higher risk for liver damage than alcohol. In fact, alcohol contributes to only 6% of liver damage. But obesity contributes to 52% of liver disease. And if you’re obese, you’re 400% more likely to develop liver damage than a normal-weight individual.1 That’s why about 30% of people in America have some form of chronic fatty liver disease. It’s called non-alcoholic fatty liver disease (NAFLD). NAFLD causes painful swelling and scarring of the liver.  And I blame...
Source: Al Sears, MD Natural Remedies - October 5, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Health Weight Loss Source Type: news

Medical News Today: Do you have diabetes, liver disease? Watch out for CVD
A new study shows that non-alcoholic fatty liver disease puts people with type 2 diabetes at a much higher risk of cardiovascular disease and death. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 13, 2017 Category: Consumer Health News Tags: Diabetes Source Type: news

Heart Benefit of Alcohol Not Seen in NAFLD Heart Benefit of Alcohol Not Seen in NAFLD
Light to moderate drinkers may have a lower risk of heart disease than teetotalers, but a new study suggests this doesn't hold true in non-alcoholic fatty liver disease (NAFLD).Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - September 7, 2017 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Nonalcoholic Fatty Liver Disease Epidemic Increasing Greatly Nonalcoholic Fatty Liver Disease Epidemic Increasing Greatly
The burden of nonalcoholic fatty liver disease (NAFLD) is increasing greatly, and the need for liver transplants is likely to outstrip the supply of donors, researchers report.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - August 31, 2017 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Efficacy of Dietary and Activity Intervention in NAFLD Efficacy of Dietary and Activity Intervention in NAFLD
What lifestyle changes are most effective at reducing steatosis or markers of NAFLD activity?BMJ Open Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 28, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Heart hormones protect against obesity and insulin resistance
(Sanford-Burnham Prebys Medical Discovery Institute) By fleshing out how one signaling receptor contributes to causing obesity through its activity in fatty tissue but not in muscle cells, SBP scientists have zeroed in on an important new avenue of exploration for combating metabolic disease. More than one-third of American adults are considered to be obese, which dramatically increases their risk for developing type 2 diabetes, non-alcoholic fatty liver disease, high blood pressure, and multiple inflammatory conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 25, 2017 Category: International Medicine & Public Health Source Type: news

Fatty liver can cause damage to other organs
NAFLD increases the risk of chronic liver disease, type 2 diabetes and cardiovascular diseases by releasing glucose, fats and proteins into the bloodstream, according to research published inScientific Reports. The secreted substances trigger reactions in other organs, causing further damage. Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - August 22, 2017 Category: Endocrinology Source Type: news

Your NEJM Group Today: Migraine Clinical Pearls / Alcohol Intake in Nonalcoholic Fatty Liver Disease / Okla. Primary Care Opportunity (FREE)
By the Editors Take a look at today's offering from NEJM Group:NEJM Resident 360: Clinical Pearls: Are … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 22, 2017 Category: Primary Care Source Type: news

Fatty liver disease: Complex condition can also damage other organs
NON-ALCOHOLIC fatty liver disease is a condition usually seen in people who are obese or overweight. (Source: Daily Express - Health)
Source: Daily Express - Health - August 21, 2017 Category: Consumer Health News Source Type: news

TRIF-dependent Toll-like receptor signaling suppresses Scd1 transcription in hepatocytes and prevents diet-induced hepatic steatosis
Nonalcoholic fatty liver disease (NAFLD) includes a spectrum of diseases that ranges in severity from hepatic steatosis to steatohepatitis, the latter of which is a major predisposing factor for liver cirrhosis and cancer. Toll-like receptor (TLR) signaling, which is critical for innate immunity, is generally believed to aggravate disease progression by inducing inflammation. Unexpectedly, we found that deficiency in TIR domain–containing adaptor-inducing interferon-β (TRIF), a cytosolic adaptor that transduces some TLR signals, worsened hepatic steatosis induced by a high-fat diet (HFD) and that such exacerbati...
Source: Signal Transduction Knowledge Environment - August 8, 2017 Category: Science Authors: Chen, J., Li, J., Yiu, J. H. C., Lam, J. K. W., Wong, C.-M., Dorweiler, B., Xu, A., Woo, C. W. Tags: STKE Research Articles Source Type: news

Reverse fatty liver disease: Drug could CURE condition caused by obesity
NON-alcoholic fatty liver disease is a condition usually seen in people who are obese or overweight, however now experts think there could be a cure. (Source: Daily Express - Health)
Source: Daily Express - Health - August 4, 2017 Category: Consumer Health News Source Type: news

Of Mice and Cheeseburgers: Experimental Drug Reverses Obesity-Related Liver Disease
A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet – non-alcoholic fatty liver disease. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - August 3, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Of mice and cheeseburgers: Experimental drug reverses obesity-related liver disease
(University of Rochester Medical Center) An experimental drug protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease. The drug reversed liver inflammation, injury and scarring in animals fed a high fat, sugar and cholesterol diet. The diet was designed to replicate the Western fast food diet and recreate the features of non-alcoholic fatty liver disease found in people. The research team plans further testing to move it into human trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2017 Category: International Medicine & Public Health Source Type: news

Risk Factors for NAFLD in Lean and Obese Patients Risk Factors for NAFLD in Lean and Obese Patients
While NAFLD is associated with obesity, it also develops in lean persons. Do pre-disposing risk factors differ between the two--or are they more similar than previously assumed?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

The Mediterranean Diet As the Diet of Choice for NAFLD The Mediterranean Diet As the Diet of Choice for NAFLD
Can the Mediterranean Diet improve management of NAFLD? This review examines the epidemiological evidence and possible molecular mechanisms which might explain its beneficial effect.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Preventive Effect of Sustained Physical Activity on NAFLD Preventive Effect of Sustained Physical Activity on NAFLD
Can sustained physical activity reduce the risk of incident NAFLD in healthy adults?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Can-Fite commences Phase II trial of namodenoson for NAFLD/NASH
Israeli biotechnology firm Can-Fite BioPharma is set to commence patient enrolment for a Phase II clinical trial of namodenoson to treat non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), following the successful conc … (Source: Drug Development Technology)
Source: Drug Development Technology - July 18, 2017 Category: Pharmaceuticals Source Type: news

Obscure Asthma Drug Shows Promise for Treating Diabetes Obscure Asthma Drug Shows Promise for Treating Diabetes
A small proof-of-concept study has suggested that the asthma drug amlexanox could be repurposed to treat type 2 diabetes and may improve nonalcoholic fatty-liver disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Improving VNS therapy: ElectroCore CEO Amato on gammaCore and its slated July launch
Neuroscience tech developer ElectroCore said recently it plans to launch its handheld gammaCore vagus nerve stimulation device in the US in mid-July, after having won clearance from the FDA in April for treating episodic cluster headaches. Unlike other vagus nerve stimulation devices, the gammaCore is an external handheld device with no implanted component, designed to be used in a pain-free procedure, CEO Frank Amato told MassDevice.com in an interview. “Its a first-of-its-kind type of device,” Amato said, speaking on the recently approved and soon-to-launch gammaCore. “Vagus nerve stimulators have been ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation Pain Management Source Type: news

Relatives of people with fatty liver cirrhosis also at risk
(Reuters Health) - If a parent or sibling has cirrhosis due to non-alcoholic fatty liver disease, a person's odds of having liver scarring are more than 12 times higher than for people without close relatives who have this condition, a small study finds. (Source: Reuters: Health)
Source: Reuters: Health - June 22, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Popular prostate drug linked to serious side effects
(Boston University Medical Center) Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2017 Category: International Medicine & Public Health Source Type: news

New study: Unsaturated fat associated with fatty liver disease
(American Gastroenterological Association) As the obesity epidemic continues, new data shed light on which nutrients and what quantity of those nutrients promote health or disease. In the American Gastroenterological Association journal, Cellular and Molecular Gastroenterology and Hepatology, scientists report on the role of macronutrients in the development of metabolically unhealthy obesity -- cases where patients have diseases with obesity as the root cause, specifically nonalcoholic fatty liver disease (NAFLD). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 14, 2017 Category: Biology Source Type: news

Short duration of breastfeeding and maternal obesity linked to fatty liver in adolescents
(Elsevier) Infants who were breastfed for less than six months before starting infant formula milk and infants who had mothers who were obese at the start of pregnancy, were much more likely to develop nonalcoholic fatty liver disease (NAFLD) as adolescents, according to a novel study in the Journal of Hepatology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2017 Category: International Medicine & Public Health Source Type: news

Relationship of NAFLD to CVD and Other Extrahepatic Diseases Relationship of NAFLD to CVD and Other Extrahepatic Diseases
Is NAFLD just one facet of a multisystem disease? This review explores the pathophysiological effects of NAFLD which extend beyond the hepatic system.Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 8, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Cellular stress in the brain may contribute to non-alcoholic fatty liver disease
(George Washington University) Research published in the Journal of Clinical Investigation Insight shows that cellular stress in the brain may contribute to development of nonalcoholic fatty liver disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 25, 2017 Category: International Medicine & Public Health Source Type: news

World's leading liver experts focus on continuing advancements in liver disease & transplantation
(Intermountain Medical Center) As the prevalence of liver disease continues to rise across the world, the growing number of people impacted by cirrhosis, liver cancer, and nonalcoholic fatty liver disease, is the focus of more than 1,700 of the world's leading liver disease experts. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 24, 2017 Category: Infectious Diseases Source Type: news

Nonobese Fatty Liver Disease Nonobese Fatty Liver Disease
What is the clinical significance of nonobese NAFLD as a liver disease, and how can we identify at-risk patients?Clinical Gastroenterology and Hepatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 19, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Inflammatory signature of nonalcoholic fatty liver disease
A team of investigators has identified key inflammatory cells involved in nonalcoholic fatty liver disease. Current treatment for the disorder involves changes to diet, yet no medication has been approved for treatment. Findings from this study provide a potential therapeutic target and offer the possibility for developing a treatment. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 16, 2017 Category: Science Source Type: news